Cambridge Heart, Inc.
Industry
- Medical Devices
- Surgical Equipment & Devices
- Monitoring Equipment & Devices
- Diagnostic Equipment & Supplies
Latest on Cambridge Heart, Inc.
CMS says there is insufficient evidence to overturn its 2008 national non-coverage decision on microvolt T-wave alternans (MTWA) sudden cardiac risk stratification testing using the modified moving av
CMS has opened the window slightly for Medicare coverage of microvolt T-wave alternans (MTWA) using the modified moving average (MMA) method to determine if patients are at risk of sudden cardiac deat
Resignations at Cambridge Heart Cambridge Heart Inc. , developer of noninvasive diagnostic tests for cardiac disease, announced Dec. 3 that both Chairman Roderick de Greef and another director, f
ICU glucose monitoring OptiScan Biomedical’s OptiScanner automated bedside glucose monitor showed highly accurate results compared to a laboratory blood glucose reference test in a study of 63 criti